Yahoo
KSE - Delayed Quote KRW

Samsung Biologics Co.,Ltd. (207940.KS)

1,516,000.00 -4,000.00 (-0.26%)
At close: November 6 at 3:30:27 PM GMT+9
View in AlphaSpace Currency in KRW All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
5,121,219,267.23
4,556,971,695.18
3,497,145,675.78
3,694,588,767.06
3,001,295,197.68
Cost of Revenue
2,332,952,908.69
2,040,331,283.53
1,785,960,975.72
1,891,824,205.77
1,532,847,164.86
Gross Profit
2,788,266,358.54
2,516,640,411.65
1,711,184,700.06
1,802,764,561.29
1,468,448,032.82
Operating Expense
459,290,338.66
447,419,144.94
389,818,319.40
689,084,551.47
484,820,638
Operating Income
2,328,976,019.88
2,069,221,266.71
1,321,366,380.66
1,113,680,009.82
983,627,394.82
Net Non Operating Interest Income Expense
18,594,159.18
16,862,389.18
20,281,139.53
14,053,655.22
-10,771,705.45
Pretax Income
2,462,386,578.86
2,118,631,252.68
1,384,868,829.74
1,119,986,931.20
1,009,024,573.71
Tax Provision
613,058,654.94
504,300,943.22
344,567,288.51
262,295,632.81
210,968,363.63
Net Income Common Stockholders
1,984,311,973.97
1,784,352,060.59
1,083,315,885.98
857,691,298.38
798,056,210.08
Basic EPS
30.97k
26.63k
15.22k
12.05k
11.44k
Diluted EPS
30.97k
26.63k
15.22k
12.05k
11.43k
Basic Average Shares
46,290.95
--
46,289.94
46,289.52
45,363.47
Diluted Average Shares
46,290.95
--
46,289.94
46,289.52
45,403.15
Total Operating Income as Reported
2,328,976,019.78
2,069,221,266.63
1,321,366,380.58
1,113,680,009.71
983,627,394.37
Total Expenses
2,792,243,247.35
2,487,750,428.47
2,175,779,295.12
2,580,908,757.24
2,017,667,802.86
Net Income from Continuing & Discontinued Operation
1,984,311,973.97
1,784,352,060.59
1,083,315,885.98
857,691,298.38
798,056,210.08
Normalized Income
1,856,130,796.09
1,621,577,889.04
1,044,045,875.92
859,691,111.03
740,492,868.45
Interest Income
51,331,504.54
46,033,670.09
54,404,315.03
95,650,057.42
53,292,640
Interest Expense
32,543,045.97
29,171,280.92
34,123,175.51
81,596,402.20
64,064,346
Net Interest Income
18,594,159.18
16,862,389.18
20,281,139.53
14,053,655.22
-10,771,705.45
EBIT
2,494,929,624.83
2,147,802,533.60
1,418,992,005.25
1,201,583,333.40
1,073,088,919.71
EBITDA
2,993,605,708.63
2,781,439,449.80
2,018,093,149.56
1,691,365,328.05
1,381,353,240.61
Reconciled Cost of Revenue
2,332,952,908.69
2,040,331,283.53
1,785,960,975.72
1,891,824,205.77
1,532,847,164.86
Reconciled Depreciation
498,676,083.80
633,636,916.20
599,101,144.31
489,781,994.65
308,264,320.90
Net Income from Continuing Operation Net Minority Interest
1,849,327,923.92
1,614,330,309.46
1,040,301,541.23
857,691,298.38
798,056,210.08
Total Unusual Items Excluding Goodwill
-9,058,048.02
-9,511,259.29
-4,984,471.10
-2,611,403.31
72,780,370
Total Unusual Items
-9,058,048.02
-9,511,259.29
-4,984,471.10
-2,611,403.31
72,780,370
Normalized EBITDA
3,002,663,756.65
2,790,950,709.09
2,023,077,620.66
1,693,976,731.36
1,308,572,870.61
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,255,175.85
-2,263,679.71
-1,240,136.41
-611,590.66
15,217,028.37
12/31/2022 - 11/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: